COMP <GO>
ACN vs TSLA // REVENUE GROWTH (YOY)
Accenture plc Class A Ordinary Shares (Ireland) (NYSE) VS. Tesla, Inc. (NASDAQ) • 15-METRIC TALLY: ACN 10
— TSLA 4
▲ REVENUE GROWTH (YOY) LEADER: TSLA
LAST: $258.24 (+4.46%) • MKT CAP: $165.32B
revenue-growth
7.40%
LAST: $399.81 (-0.87%) • MKT CAP: $1.58T
revenue-growth
8.30%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ACN VS. TSLA)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | ACN | TSLA | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 31.90% | 19.29% | +12.61 | ACN | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 23.60% | 3.39% | +20.21 | ACN | /roic <GO> |
| EV/EBITDA & P/E Valuation | 15.7x | 199.0x | -183.34 | ACN | /valuation <GO> |
| Free Cash Flow Yield | 6.58% | 0.21% | +6.37 | ACN | /fcf-yield <GO> |
| Operating Margin | 14.70% | 3.35% | +11.35 | ACN | /operating-margins <GO> |
| Net Profit Margin | 11.00% | 3.11% | +7.89 | ACN | /net-margins <GO> |
| Revenue Growth (YoY) ACTIVE | 7.40% | 8.30% | -0.90 | TSLA | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 5.42 | 15.35 | -9.93 | TSLA | /balance-sheet <GO> |
| Piotroski F-Score Quality | 8/9 | 5/9 | +3.00 | ACN | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 6.80% | 8.72% | -1.92 | ACN | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 70.1 | 60.9 | +9.25 | ACN | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.96 | 1.89 | -0.93 | TSLA | /macro-sensitivity <GO> |
| Forward P/E Multiple | 20.0x | 174.4x | -154.43 | ACN | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $165.32B | $1.58T | -$1.42T | TSLA | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | ACN REV | TSLA REV | ACN GROSS % | TSLA GROSS % | ACN FCF | TSLA FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $69.67B | $94.83B | 31.9% | 18.0% | $10.87B | $6.22B |
| FY 2024 | $64.90B | $97.69B | 32.6% | 17.9% | $8.61B | $3.58B |
| FY 2023 | $64.11B | $96.77B | 44.0% | 18.3% | $6.64B | $4.36B |
| FY 2022 | — | $81.46B | — | 25.6% | — | $7.57B |
| FY 2021 | — | $53.82B | — | 25.3% | — | $5.01B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ACN // BETA 0.96
TSLA // BETA 1.89